GL Ventures and Temasek led a USD230m Series C for Clover Biopharmaceuticals, a China-based clinical-stage biotechnology company and vaccine developer, with participation from Oceanpine Capital and OrbiMed, and follow-on from Delos Capital. Read more… Read More
Gulf Capital has exited its 70% stake in Turknet Iletisim Hizmetleri (Turknet) via a sale to a consortium of buyers including Celebiler Family and Re-Pie Portfoy Yonetimi. Gulf Capital originally invested in Turknet via its Gulf Capital Credit Opportunities Fund I in 2013. Read more… Read More
OrbiMed and WuXi Huiying Investment led a USD40m Series C for AnchorDx, a China-based medical technology developer focused on DNA sequencing and diagnostics. Read more… Read More
Volition Capital led a USD68m investment in Creatio, a Ukraine-based software company providing a low-code platform for process management and CRM, with participation from Horizon Capital. Read more… Read More
IFC has invested USD10m in AgVentures II. The fund, which is managed by SP Ventures, targets investments in agtech companies in Latin America. This marks a third fund close for AgVentures II at BRL160m (approximately USD29.7m). Read more… Read More
KKR has agreed to acquire a majority stake in the existing fiber optic network of Telefonica Chile in order to establish an open access wholesale fiber optics company. As part of the agreement, Telefonica will hold a 40% stake in the new company. The transaction is valued at… Read More
Earlybird Venture Capital has reached a EUR200m (approximately USD241m) final close for its Digital East Fund II, a vehicle targeting early-stage investments in Emerging Europe. Read more… Read More
Winter Capital Partners and the Russia-China Technology Investment Fund have invested USD10m in Algorithmics, an international school of mathematics and programming based in Russia, as part of the company’s Series A. Winter Capital Partners also acquired Algorithmics stakes from a number of minority shareholders. Read more… Read More
Lilly Asia Ventures led a USD90m Series B for Regor Therapeutics, a China-based clinical stage biotechnology company dedicated to the discovery of innovative medicines to treat cancer, immune disorders, and metabolic diseases. Loyal Valley Capital, Lanting Capital, TF Capital, and Vertex Ventures China also participated in the round. Read More
Sequoia Capital China led a USD2b funding round for China-based community grocery shopping app Xingsheng Youxuan, with participation from FountainVest Partners, Primavera Capital Group, KKR, Tencent Holdings, Temasek, and China Evergrande Group. Read more… Read More
(default archive template)